William Blair & Company’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-232
| Closed | -$18.1K | – | 1878 |
|
|
2023
Q1 | $18.1K | Hold |
232
| – | – | ﹤0.01% | 1689 |
|
|
2022
Q4 | $19.3K | Sell |
232
-500
| -68% | -$41.7K | ﹤0.01% | 1687 |
|
|
2022
Q3 | $67K | Sell |
732
-907
| -55% | -$83K | ﹤0.01% | 1556 |
|
|
2022
Q2 | $245K | Buy |
1,639
+30
| +2% | +$4.48K | ﹤0.01% | 1343 |
|
|
2022
Q1 | $390K | Buy |
1,609
+134
| +9% | +$32.5K | ﹤0.01% | 1259 |
|
|
2021
Q4 | $446K | Buy |
1,475
+1,287
| +685% | +$389K | ﹤0.01% | 1260 |
|
|
2021
Q3 | $78K | Hold |
188
| – | – | ﹤0.01% | 1644 |
|
|
2021
Q2 | $57K | Sell |
188
-562
| -75% | -$170K | ﹤0.01% | 1678 |
|
|
2021
Q1 | $154K | Buy |
750
+125
| +20% | +$25.7K | ﹤0.01% | 1529 |
|
|
2020
Q4 | $125K | Buy |
+625
| New | +$125K | ﹤0.01% | 1521 |
|
|
2018
Q2 | – | Sell |
-138
| Closed | -$75K | – | 1624 |
|
|
2018
Q1 | $75K | Buy |
+138
| New | +$75K | ﹤0.01% | 1298 |
|